1 Min Read
April 10 (Reuters) - Akers Biosciences Inc -
* Akers Biosciences to commercialize heparin PF4 rapid test in Puerto Rico Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.